PET imaging of dopamine transporters in the human brain using [11C]-β-CPPIT, a cocaine derivative lacking the 2β-ester function
- 31 January 2002
- journal article
- clinical trial
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 29 (1) , 19-27
- https://doi.org/10.1016/s0969-8051(01)00271-2
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- 18F-labeled FECNT: a selective radioligand for PET imaging of brain dopamine transportersNuclear Medicine and Biology, 2000
- The labelling of a novel tropane derivative [11C]NS 2214 (BMS-204756)-an inhibitor of the dopamine transporterJournal of Labelled Compounds and Radiopharmaceuticals, 1997
- PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's diseaseBrain, 1997
- [11C]?-CIT-FE, a radioligand for quantitation of the dopamine transporter in the living brain using positron emission tomographySynapse, 1996
- The metabolite pattern of [123I]β-CIT determined with a gradient HPLC methodNuclear Medicine and Biology, 1995
- Secondary Amine Analogs of 3.beta.-(4'-Substituted phenyl)tropane-2.beta.-carboxylic Acid Esters and N-Norcocaine Exhibit Enhanced Affinity for Serotonin and Norepinephrine TransportersJournal of Medicinal Chemistry, 1994
- Dopamine uptake sites in Parkinson's disease and in dementia of the Alzheimer typeBrain Research, 1994
- Pet study of [11C] β‐CIT binding to monoamine transporters in the monkey and human brainSynapse, 1994
- Mapping cocaine binding sites in human and baboon brain in vivoSynapse, 1989
- In vivoevaluation of striatal dopamine reuptake sites using 11C-nomifensine and positron emission tomographyActa Neurologica Scandinavica, 1987